The Digitome: a platform for enabling rapid decentralization, personalization and recruitment for clinical trials | eyeforpharma


FREE WEBINAR | November 12th, 2019

3pm London / 4pm Paris / 10am New York / 7am San Francisco


“Today, medicines work well in only a fraction of a target patient population. Not only is this a disservice to hundreds of thousands of patients, it is also a huge contributing factor to the poor performance and failure of many clinical trials.”

https://www.eyeforpharma.com/philadelphia/webinar

In Partnership With:


This is going to be an interesting discussion regarding #DigitalClinincalTrials, #DigitalTrials.


Discover the algorithms that canvass different datasets to help find the necessary unique patient populations’ with the aim of creating personalised trials.

You can find out how to virtually connect eligible patients for pre-screening’ as well as how to use ‘telemedicine to further reduce on-site screening failures‘.

Learn how to ‘improve trial design, site selection and predict results‘ through using ‘Machine Learning‘ – adjust your inclusion and exclusion criteria accordingly.

The big picture: a new trend in the use of digital biomarkers to build a picture of your own unique homeostasis and relying on technology to determine when deviations need attention

https://www.eyeforpharma.com/philadelphia/webinar

Discover the #algorithms that ‘canvass different #datasets’ to help find the necessary ‘unique #patientpopulations’ with the aim of creating #personalisedtrials. @eyeforpharma webinar #digitaltrials


Panelists include:




  • Michelle Longmire | CEO – Medable

  • Adama Ibrahim | Associate Director, POC, Global Clinical Operations – Biogen

Moderator: Paul Simms Chairman – eyeforpharma



Sign up now to be part of a very exciting session!

https://www.eyeforpharma.com/philadelphia/webinar/


Learn how to ‘improve #trialdesign, site selection and #predictresults’ through using ‘#MachineLearning’ – adjust your inclusion and exclusion criteria accordingly. @eyeforpharma webinar #digitaltrials



eyeforpharma Ltd by Reuters Events, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909.





FibroFlutters supporting eyeforpharma by Reuters as Patient, Health, Research & Pharma advocates, we are non-commercial.




FibroFlutters fancy logo
Fancy Logo © FibroFlutters



FIBROFLUTTERS CHRONIC, INVISIBLE & RARE ILLNESS SUPPORT

Patient Advocacy Organisation & Online Community Support


Patient * Health * Research * Pharma * Advocacy


Locally we’re a Support Group for people with Fibromyalgia, Chronic Pain, EDS/Hypermobility, Mental health, Chronic fatigue/Me, Rare & others offering friendship, support & advice in Sunderland, NE UK … 
… but we also offer online support, advice and advocacy via our social media network , chronic illness portal, across the globe.



Please can you read our ‘Disclaimer’ & ‘Privacy’ notes
and if you have a problem we are always open to discussion, just e-mail Carole


PLEASE NOTE: We are not medical professionals, but as patients we are sharing news, articles, information and resources out to you as all stakeholders to help keep you up to date within the Medical healthcare industries and chronic illness health, rare disease and our advocacy work for patients, health, research and pharma, including digital and AI in medicine.


PLEASE NOTE: THAT THIS SITE USES GOOGLE ANALYTICS TO COLLECT DEMOGRAPHIC INFORMATION FOR INFORMATION AND CONTENT DECISION MAKING PURPOSES ONLY AND NOT TO SELL TO 3RD PARTIES.


MANY THANKS in advance for your understanding –
from the administrator – fibrofly73 aka Carole



See our About Us pages




Social links



And my profile on Synapse where you can read about the initiatives that I am involved with

https://synapse.pfmd.org/experts/O6wWb7Kd

FibroFlutters on Synapse where you can read about the initiatives that we are involved with

https://synapse.pfmd.org/organizations/fibroflutters